EP1059533A4 - Method for immunochemically assaying anti-hm1.24 antibody - Google Patents

Method for immunochemically assaying anti-hm1.24 antibody

Info

Publication number
EP1059533A4
EP1059533A4 EP99906489A EP99906489A EP1059533A4 EP 1059533 A4 EP1059533 A4 EP 1059533A4 EP 99906489 A EP99906489 A EP 99906489A EP 99906489 A EP99906489 A EP 99906489A EP 1059533 A4 EP1059533 A4 EP 1059533A4
Authority
EP
European Patent Office
Prior art keywords
antibody
soluble
antigen protein
assaying anti
immunochemically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP99906489A
Other languages
German (de)
French (fr)
Other versions
EP1059533A1 (en
Inventor
Yasuko Ozaki
Yasuo Koishihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to EP06025157A priority Critical patent/EP1757941B1/en
Publication of EP1059533A1 publication Critical patent/EP1059533A1/en
Publication of EP1059533A4 publication Critical patent/EP1059533A4/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

An immunochemical assay for anti-HM1.24 antibody, said method comprising the steps of reacting soluble HM1.24 antigen protein and anti-HM1.24 antibody contained in a test sample, and then detecting or determining the anti-HM1.24 antibody bound to the soluble HM1.24 antigen protein; and, an immunochemical assay for soluble HM1.24 antigen protein, said method comprising the steps of reacting anti-HM1.24 antibody and soluble HM1.24 antigen protein contained in a test sample, and then detecting or determining the soluble HM1.24 antigen protein bound to the anti-HM1.24 antibody.
EP99906489A 1998-02-25 1999-02-25 Method for immunochemically assaying anti-hm1.24 antibody Ceased EP1059533A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06025157A EP1757941B1 (en) 1998-02-25 1999-02-25 Method for immunochemically assaying anti-hm1.24 antibody

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6061398 1998-02-25
JP6061398 1998-02-25
PCT/JP1999/000885 WO1999043703A1 (en) 1998-02-25 1999-02-25 Method for immunochemically assaying anti-hm1.24 antibody

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP06025157A Division EP1757941B1 (en) 1998-02-25 1999-02-25 Method for immunochemically assaying anti-hm1.24 antibody

Publications (2)

Publication Number Publication Date
EP1059533A1 EP1059533A1 (en) 2000-12-13
EP1059533A4 true EP1059533A4 (en) 2005-02-09

Family

ID=13147307

Family Applications (2)

Application Number Title Priority Date Filing Date
EP06025157A Expired - Lifetime EP1757941B1 (en) 1998-02-25 1999-02-25 Method for immunochemically assaying anti-hm1.24 antibody
EP99906489A Ceased EP1059533A4 (en) 1998-02-25 1999-02-25 Method for immunochemically assaying anti-hm1.24 antibody

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP06025157A Expired - Lifetime EP1757941B1 (en) 1998-02-25 1999-02-25 Method for immunochemically assaying anti-hm1.24 antibody

Country Status (6)

Country Link
EP (2) EP1757941B1 (en)
JP (1) JP3609026B2 (en)
AT (1) ATE462975T1 (en)
AU (1) AU2640399A (en)
DE (1) DE69942215D1 (en)
WO (1) WO1999043703A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001246846A1 (en) * 2000-04-06 2001-10-23 Chugai Seiyaku Kabushiki Kaisha Immunoassay of anti-hm1.24 antibody
ATE457318T1 (en) 2000-12-28 2010-02-15 Kyowa Hakko Kirin Co Ltd MONOCLONAL ANTIBOD DIRECTED AGAINST THE HUMAN BST2 ANTIGEN
EP1378752A4 (en) * 2001-04-13 2004-08-04 Chugai Pharmaceutical Co Ltd Method of quantifying antigen expression
EP1559432B1 (en) * 2002-10-30 2009-08-12 Chugai Seiyaku Kabushiki Kaisha Hm1.24-utilizing cancer vaccines
US8435530B2 (en) 2004-06-11 2013-05-07 Sbi Biotech Co., Ltd. Methods for suppressing activity of activated interferon-producing cells
US20080299128A1 (en) * 2006-06-20 2008-12-04 Myung Kim Effect of Bst2 on inflammation
US8329186B2 (en) 2004-12-20 2012-12-11 Isu Abxis Co., Ltd Treatment of inflammation using BST2 inhibitor
US7740856B2 (en) 2005-12-20 2010-06-22 Isu Abxis Co., Ltd. Effect of BST2 on inflammation
CA2620626C (en) 2004-12-20 2011-06-07 Isu Abxis Co., Ltd. Molecules inhibiting intercellular adhesion
JP5562031B2 (en) 2006-09-18 2014-07-30 ゼンコー・インコーポレイテッド Optimized antibody targeting HM1.24
WO2021081880A1 (en) * 2019-10-31 2021-05-06 中国科学院深圳先进技术研究院 Hybridoma cell strain and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374520A (en) * 1985-12-13 1994-12-20 The Johns Hopkins University Assay method for Epstein-Barr virus antibodies
EP0972524A1 (en) * 1997-02-28 2000-01-19 Chugai Seiyaku Kabushiki Kaisha Lymphocyte activation inhibitors
EP1020522A1 (en) * 1997-10-03 2000-07-19 Chugai Seiyaku Kabushiki Kaisha Natural human antibody

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA76934C2 (en) * 1996-10-04 2006-10-16 Chugai Pharmaceutical Co Ltd Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody
AU724133B2 (en) * 1997-02-12 2000-09-14 Chugai Seiyaku Kabushiki Kaisha Remedies for lymphocytic tumors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374520A (en) * 1985-12-13 1994-12-20 The Johns Hopkins University Assay method for Epstein-Barr virus antibodies
EP0972524A1 (en) * 1997-02-28 2000-01-19 Chugai Seiyaku Kabushiki Kaisha Lymphocyte activation inhibitors
EP1020522A1 (en) * 1997-10-03 2000-07-19 Chugai Seiyaku Kabushiki Kaisha Natural human antibody

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
OZAKI K ET AL: "LOCALIZATION AND IMAGING OF HUMAN PLASMACYTOMA XENOGRAFTS IN SEVERE COMBINED IMMUNODEFICIENCY MICE BY A NEW MURINE MONOCLONAL ANTIBODY, ANTI-HM1.24", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 43, 1996, pages 7 - 15, XP002912306, ISSN: 0022-1007 *
OZAKI S ET AL: "Radioimmunodetection of human myeloma xenografts with a monoclonal antibody directed against a plasma cell specific antigen, HM1.24", CANCER, AMERICAN CANCER SOCIETY, PHILADELPHIA, PA, US, vol. 82, no. 11, 1 June 1998 (1998-06-01), pages 2184 - 2190, XP002276962, ISSN: 0008-543X *

Also Published As

Publication number Publication date
EP1757941A1 (en) 2007-02-28
WO1999043703A1 (en) 1999-09-02
WO1999043703A8 (en) 1999-12-02
JP3609026B2 (en) 2005-01-12
AU2640399A (en) 1999-09-15
EP1059533A1 (en) 2000-12-13
DE69942215D1 (en) 2010-05-12
EP1757941B1 (en) 2010-03-31
ATE462975T1 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
EP0809111A3 (en) Analyzing method utilizing oligomeric receptors
TW348216B (en) Method for the determination of urinary protein and creatinine
AU4926085A (en) Immunoassays for protein analytes, particularly HB A1c, involving sample denaturation
WO1999041584A3 (en) METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
EP1059533A4 (en) Method for immunochemically assaying anti-hm1.24 antibody
EP0383313A3 (en) Reagent for immunoassay, and kit containing the same
AU3059499A (en) Solid-phase method for antigen and antibody determinations in bloodgroup serology, and test kit
CA2193323A1 (en) Process for preparing a synthetic calibrator for use in sandwich immunoassays, which calibrator consists of an antibody against one of the antibodies used in the assay and of a sequence of the analyte
EP1424558A4 (en) Reagent for assaying laminin 5 antigen in biological sample and assay method
NO20083610L (en) Cobalamin-paint
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
EP0829723A3 (en) Homogeneous detection method for the determination of sub-populations of an analyte
CA2366651A1 (en) A method for detecting megsin protein and use thereof
CA2074556A1 (en) Immunological detection method
EP0387027A3 (en) Endometriosis diagnosis methods and reagents
CA2213083A1 (en) Detection of antibody production
IL108811A0 (en) Immunoassay reagents, kits and methods
EP0250119A3 (en) Atherosclerotic anti-idiotype antibody immunoassay and reagents
CA2198948A1 (en) Quantitative detection of analytes on immunochromatographic strips
EP0368674A3 (en) Immunoassay and test kits therefor
HK1012710A1 (en) Equipment and test for determining an antigen/antibody in a test sample
CA2304980A1 (en) Immunoassay to detect herpesvirus specific igm
ES2120888A1 (en) Quantitative immunoenzymatic method for detecting the adulteration of ewe's milk with milk of another species.
CA2051618A1 (en) Immunoassay for pyridostigmine
AU6642698A (en) Immunoassay and kit for iga antibodies specific for acetaldehyde adducts

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000825

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20041228

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12P 21/02 B

Ipc: 7C 12P 21/08 B

Ipc: 7C 07K 16/18 B

Ipc: 7C 12N 15/12 B

Ipc: 7C 07K 19/00 B

Ipc: 7C 07K 14/47 B

Ipc: 7G 01N 33/577 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20070301